alpha(9)beta(1) integrin engagement inhibits neutrophil spontaneous apoptosis: involvement of Bcl-2 family members.
alpha(9)beta(1) integrin engagement inhibits neutrophil spontaneous apoptosis: involvement of Bcl-2 family members.
复制标题
DOI:
10.1016/j.bbamcr.2010.03.012
复制
发表时间:
2010-07
期刊:
影响因子:
--
通讯作者:
R. Saldanha-Gama;J. Moraes;Andréa Mariano-Oliveira;A. L. Coelho;E. Walsh;C. Marcinkiewicz;C. Barja-Fidalgo
中科院分区:
文献类型:
--
作者:
R. Saldanha-Gama;J. Moraes;Andréa Mariano-Oliveira;A. L. Coelho;E. Walsh;C. Marcinkiewicz;C. Barja-Fidalgo
Integrin signaling is comprised of well-characterized pathways generally involved in cell survival. α9β1integrin has recently become a target of study and has been shown to present pro-survival effects on neutrophils. However, there are no detailed studies on how α9β1integrin-coupled signaling pathways interact and how they converge to finally modulate spontaneous apoptosis in neutrophils. In this regard we sought to investigate the main signaling events triggered by α9β1integrin engagement and how these signaling pathways modulate the apoptotic program of human neutrophils. Using VLO5, a snake venom disintegrin shown to bind to α9β1integrin in neutrophils, we demonstrate that α9β1integrin engagement leads to the activation of integrin signaling pathways and potently reduces neutrophil spontaneous apoptosis. These effects are dependent on the activation of PI3K and MAPK pathways, since both LY294002 (PI3K inhibitor) or PD95059 (MEK inhibitor) reverted the effects of VLO5/α9β1interaction. Moreover we show that VLO5/α9β1engagement induces NF-κB nuclear translocation and increases the ratio between anti- and pro-apoptotic proteins by inducing the degradation of pro-apoptotic protein Bad and increasing the expression of anti-apoptotic protein Bcl-xL. VLO5 also inhibited the early steps of neutrophil spontaneous apoptosis by preventing Bax translocation to the outer mitochondrial membrane and consequent cytochrome c release. In conclusion, as the mechanistic details of α9β1integrin signaling pathways in human neutrophils becomes clearer, it should become possible to develop new therapeutic agents for human diseases where neutrophils play a prominent role.